177 related articles for article (PubMed ID: 16728266)
1. Minor histocompatibility antigens: from transplantation problems to therapy of cancer.
Goulmy E
Hum Immunol; 2006 Jun; 67(6):433-8. PubMed ID: 16728266
[TBL] [Abstract][Full Text] [Related]
2. The relevance of minor histocompatibility antigens in solid organ transplantation.
Dierselhuis M; Goulmy E
Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
[TBL] [Abstract][Full Text] [Related]
3. Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.
Rufer N; Starobinski M; Chapuis B; Gratwohl A; Jeannet M; Helg C; Roosnek E
Bone Marrow Transplant; 1998 Nov; 22(9):895-8. PubMed ID: 9827818
[TBL] [Abstract][Full Text] [Related]
4. Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantation.
Turpeinen H; Volin L; Partanen J
Tissue Antigens; 2009 Mar; 73(3):236-41. PubMed ID: 19254253
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of cancer through targeting of minor histocompatibility antigens.
Hambach L; Goulmy E
Curr Opin Immunol; 2005 Apr; 17(2):202-10. PubMed ID: 15766682
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.
Hambach L; Spierings E; Goulmy E
Best Pract Res Clin Haematol; 2007 Jun; 20(2):171-87. PubMed ID: 17448955
[TBL] [Abstract][Full Text] [Related]
7. Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
Kotzampasaki EM; Spyropoulou-Vlachou MS; Kalofoutis C; Vrani V; Kalofoutis A; Stavropoulos-Giokas C
Transplant Proc; 2004; 36(6):1735-8. PubMed ID: 15350465
[TBL] [Abstract][Full Text] [Related]
8. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?
Lerut E; Van Damme B; Noizat-Pirenne F; Emonds MP; Rouger P; Vanrenterghem Y; Pirenne J; Ansart-Pirenne H
Transfusion; 2007 Jan; 47(1):28-40. PubMed ID: 17207227
[TBL] [Abstract][Full Text] [Related]
9. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
Spierings E
Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
[TBL] [Abstract][Full Text] [Related]
10. Improving the outcome of unrelated donor stem cell transplantation by molecular matching.
Shaw BE; Madrigal JA; Potter M
Blood Rev; 2001 Dec; 15(4):167-74. PubMed ID: 11792117
[TBL] [Abstract][Full Text] [Related]
11. Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.
Spaapen R; Mutis T
Best Pract Res Clin Haematol; 2008 Sep; 21(3):543-57. PubMed ID: 18790454
[TBL] [Abstract][Full Text] [Related]
12. HA-1 mismatch has significant effect in chronic allograft nephropathy in clinical renal transplantation.
Krishnan NS; Higgins RM; Lam FT; Kashi H; Jobson S; Ramaiyan K; Rahman M; Morris A
Transplant Proc; 2007 Jun; 39(5):1439-45. PubMed ID: 17580157
[TBL] [Abstract][Full Text] [Related]
13. Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy.
Goulmy E
Cancer J; 2004; 10(1):1-7. PubMed ID: 15000488
[TBL] [Abstract][Full Text] [Related]
14. RE: Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
Brickner AG
Transplant Proc; 2005 Dec; 37(10):4640-1; author reply 4641. PubMed ID: 16387190
[No Abstract] [Full Text] [Related]
15. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.
Reichenbach J; Van de Velde H; De Rycke M; Staessen C; Platteau P; Baetens P; Güngör T; Ozsahin H; Scherer F; Siler U; Seger RA; Liebaers I
Pediatrics; 2008 Sep; 122(3):e778-82. PubMed ID: 18762514
[TBL] [Abstract][Full Text] [Related]
16. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
17. Matching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation.
Böhringer D; Spierings E; Enczmann J; Böhringer S; Sundmacher R; Goulmy E; Reinhard T
Transplantation; 2006 Oct; 82(8):1037-41. PubMed ID: 17060851
[TBL] [Abstract][Full Text] [Related]
18. The role of minor histocompatibility antigens in GVHD and rejection: a mini-review.
Goulmy E; Voogt P; van Els C; de Bueger M; van Rood J
Bone Marrow Transplant; 1991; 7 Suppl 1():49-51. PubMed ID: 2043886
[No Abstract] [Full Text] [Related]
19. Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.
Dierselhuis MP; Spierings E; Drabbels J; Hendriks M; Alaez C; Alberú J; Alvarez MB; Burlingham W; Campos E; Christiaans M; Claas F; Fasano ME; Gerbase-Delima M; Gervais T; Gorodezky C; Larriba J; Lardy NM; Latinne D; Morales-Buenrostro LE; Moreno MJ; Oguz F; Opelz G; Sergeant R; Tambutti M; Teper S; Tilanus M; Turkmen A; Warrens AN; Weimar W; Goulmy E
Tissue Antigens; 2013 Nov; 82(5):312-6. PubMed ID: 24116658
[TBL] [Abstract][Full Text] [Related]
20. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
